Delivery Order SPE2DB20D7059-SPE2DB24FPZZ9

Award Date 2/28/24
Potential Completion Date 2/29/24
Potential Value $30K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the ROTARIX vaccine oral syringe, 1.5 milliliters, at a ceiling value of $5,231.01. The contract is a firm fixed price, delivery order type and has a period of performance through September 6, 2024. This order is not associated with a set-aside program. AmerisourceBergen holds an...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,654.02 firm fixed-price contract is for the delivery of the ROTARIX vaccine oral syringes (1.5 mL) and has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major global pharmaceutical distribution company. The $2,845.63 order is for the ROTARIX oral vaccine syringe, 1.5 mL. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTARIX vaccine oral syringe 1.5ML. The $2,929.56 firm fixed-price contract has an ultimate completion date of October 22, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $30,589.56 firm-fixed-price contract is for the supply of ROTARIX vaccine oral syringes (1.5 mL) to support military healthcare programs. The contract has a completion date of September 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and other federal agencies,...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $10,268.58 for the provision of ROTARIX vaccine oral syringes. The award has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this order is fulfilled under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $6,687.66 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide ROTARIX VACCINE ORAL SYRINGE 1.5ML. This award is part of an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. The IDC, valued up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for $2,153.70 and covers the delivery of the ROTARIX vaccine oral syringes (1.5 ml) through August 2024. The award is not set aside for any special designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with significant Indefinite Delivery Contracts (IDCs)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,193.06 firm fixed-price contract is for the delivery of the ROTARIX vaccine oral syringe 1.5 ML. The contract has an ultimate completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
The Defense Logistics Agency has awarded a firm fixed price delivery order worth $7,880.13 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ROTARIX VACCINE ORAL SYRINGE 1.5ML. This order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FPZZ9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of ROTARIX VACCINE ORAL SYRINGE 1.5ML, a pharmaceutical product, for a firm fixed price of $29,581.50. The contract has a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to support Department of Defense medical treatment programs and facilities worldwide. This specific delivery order is issued under that IDC. No set-aside designation was used for this award.

Generated 5/29/24, 10:13 AM